Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A spectrum of connective tissue disorders characterized by the association of wrinkled, redundant and sagging inelastic skin with growth and developmental delay, and skeletal anomalies. The spectrum ranges from patients with classic ARCL2 (ARCL, Debre) type) to patients with a milder form of the disease, wrinkled skin syndrome (WSS).
No HPO annotations are available for this condition.
ATP6V0A2-related cutis laxa is characterized by generalized cutis laxa, findings associated with generalized connective tissue disorder, developmental delays, and a variety of neurologic findings including abnormality on brain MRI. This disorder spans a phenotypic spectrum that includes the historical diagnoses of Debr-type cutis laxa at the severe end and wrinkly skin syndrome at the mild end; these two phenotypes were thought to be distinct clinical entities until their molecular genetic nature was determined. Children diagnosed in the past with Debr-type cutis laxa had more severe developmental and neurologic abnormalities and a less severe cutaneous phenotype than children diagnosed with wrinkly skin syndrome, in whom the skin showed tighter wrinkles and the changes in facial features were milder . To date, about 80 individuals have been identified with a pathogenic variant in ATP6V0A2 [; Authors, unpublished observations]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. ATP6V0A2-Related Cutis Laxa: Frequency of Select Features
ATP6V0A2-related cutis laxa, also known as autosomal recessive cutis laxa type 2A (ARCL2A), should be considered in individuals with the following findings.
Clinical Findings
Characteristic signs of cutis laxa
Furrowing of the skin of the whole body; particularly obvious in neck, axillae, and groin
No approved treatments are currently available for autosomal recessive cutis laxa type 2. The disease remains an area of unmet medical need.
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with ATP6V0A2-related cutis laxa, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with ATP6V0A2-Related Cutis Laxa
Table 6.
Recommended Surveillance for Individuals with ATP6V0A2-Related Cutis Laxa
System/Concern | Evaluation | Frequency
| Ophthalmologic exam, incl refraction for evidence of progressive myopia fundus exam to inspect Bruch's membrane | Annually
No clinical trials have been registered for autosomal recessive cutis laxa type 2.
4 publications have been identified in PubMed for autosomal recessive cutis laxa type 2. Kisho has analyzed 3 by research type. Research spans Case Report / Case Series (67%) and Basic Science / Preclinical (33%).
Chandan S (2025). [PMID: 40018427](https://pubmed.ncbi.nlm.nih.gov/40018427/). *Clinical case reports*. [Case Report / Case Series]
Shangguan S (2024). [PMID: 39172257](https://pubmed.ncbi.nlm.nih.gov/39172257/). *Molecular genetics and genomics : MGG*. [Case Report / Case Series]
Kopp J (2024). [PMID: 39680136](https://pubmed.ncbi.nlm.nih.gov/39680136/). *Cell Mol Life Sci*. [Basic Science / Preclinical]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Feature | % of Persons w/Feature | Comment |
|---|---|---|
Cutis laxa | 100% | Combination of fine wrinkles sagging skin; can vanish during childhood. |
Prominent nasal root | 100% | — |
Downslanted palpebral fissures | 100% | Recognizable facial dysmorphism |
Enlarged fontanels w/delayed closure | 100% | — |
Congenital dislocation of hips | 60% | — |
Inguinal hernia | 60% | — |
High myopia | 20% | — |
Other ophthalmic issues | 20% | — |
Developmental delay/Intellectual disability | 100% | Always speech delay; some can attend normal school |
Seizure disorder | 100% | Onset variable; may occur as late as adolescence |
Neurologic decline | Possibly up to 40% | Unclear; few w/follow-up data |
Abnormal brain imaging | 90% | Brain malformation experts can make diagnosis from MRI. Presentation and progression. At birth, hypotonia, overfolded skin, and distinctive facial features are present and enlarged fontanelles are often observed. |
Source: GeneReviews — "ATP6V0A2-Related Cutis Laxa"
Droopy skin on the cheeks of the face and marked nasolabial folds, giving rise to distinctive facial features that also include prominent nasal root and downslanted palpebral fissures
Other evidence of a generalized connective tissue disorder
Source: GeneReviews — "ATP6V0A2-Related Cutis Laxa"
Other disorders characterized by cutis laxa are summarized in . Table 3. Disorders to Consider in the Differential Diagnosis of ATP6V0A2-Related Cutis Laxa
Gene | Disorder | MOI | Clinical Findings | Comment |
|---|---|---|---|---|
Cutis laxa | Emphysema | Aneurysms | ID/DD | Bladderdiverticulae |
ALDH18A1 | De Barsy syndrome A (ARCL3A) (See Neurocutaneous Disorders due to Mitochondrial Proline Synthesis Defects.) | AR | + | – |
ADCL3 (See Neurocutaneous Disorders due to Mitochondrial Proline Synthesis Defects.) | AD | + | – | – |
ATP6V1A | ARCL2D (OMIM 617403) | AR | ++ | – |
ATP6V1E1 | ARCL2C (OMIM 617402) | AR | ++ | – |
EFEMP2-related cutis laxa | AR | ++ | ++ | +++ |
ELN | ELN-related cutis laxa (ADCL1) | AD | + | + |
EMILIN1 | EMILIN1-related cutis laxa1 | AR | + | – |
FBLN5 | FBLN5-related cutis laxa (ARCL1A ADCL2) | ARAD | +++ | +++ |
GORAB | Gerodermia osteodysplastica (GO) (OMIM 231070) | AR | ++ | – |
LTBP4 | LTBP4-related cutis laxa (URDS, ARCL1C) | AR | + | ++ |
NBAS | Short stature, optic nerve atrophy, Pelger-Huet anomaly (SOPH syndrome) (OMIM 614800) | AR | + | – |
PTDSS1 | Lenz-Majewski syndrome hyperostotic dwarfism (LMS) (OMIM 151050) | AD | + | – |
PYCR1 | De Barsy syndrome B (ARCL3B) (See Neurocutaneous Disorders due to Mitochondrial Proline Synthesis Defects.) | AR | + | – |
ARCL2B (See Neurocutaneous Disorders due to Mitochondrial Proline Synthesis Defects.) | AR | + | – | – |
RIN2 | RIN2-related cutis laxa (MACS syndrome) (OMIM 613075) | AR | + | – |
Arterial tortuosity syndrome | AR | + | – | ++ |
Source: GeneReviews — "ATP6V0A2-Related Cutis Laxa"
System/Concern | Evaluation | Comment |
|---|---|---|
Inguinal hernia(s) | Clinical eval | Cardiac valvular |
dysplasia | Echocardiogram | High myopia other ophthalmic |
abnormality | Ophthalmologic exam, incl refraction (for myopia), slit-lamp exam, fundus exam | Slit-lamp exam allows diagnosis of corneal dysplasia (seen in 1 person). DD/ID/ Neurologic abnormality |
deficiencies | Full screening, incl von Willebrand factor | — |
Genetic counseling | By genetics professionals1 | To obtain a pedigree inform affected persons their families re nature, MOI, implications of ATP6V0A2-related cutis laxa to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with ATP6V0A2-Related Cutis Laxa Manifestation/Concern | Treatment | Considerations/Other |
Congenital hip dislocation | Standard treatment as recommended by orthopedist | — |
Inguinal hernia(s) | Surgical repair | — |
High myopia | Standard treatment(s) as recommended by ophthalmologist | — |
DD/ID | See . | — |
Seizure disorder | Standardized treatment w/ASM by experienced neurologist | See footnote 1. |
Self-image difficulties related to cutis laxa | Psychological help as needed | ASM = anti-seizure medication; DD = developmental delay; ID = intellectual disability Education of parents/caregivers regarding common seizure presentations is appropriate. |
Source: GeneReviews — "ATP6V0A2-Related Cutis Laxa"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "ATP6V0A2-Related Cutis Laxa"
View trials for autosomal recessive cutis laxa type 2
Source: GeneReviews — "ATP6V0A2-Related Cutis Laxa"
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).